For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| DU-176b | DU-176b oral tablets, 30 mg., taken once daily for 2 weeks edoxaban | None | None | 9 | 303 | 197 | 303 | View |
| Enoxaparin Sodium | enoxaparin sodium 20mg(=2000IU)/0.2ml twice daily, subcutaneous injection for 2 weeks enoxaparin sodium | None | None | 9 | 301 | 232 | 301 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| femur fracture | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA/JV.12.0 | View |
| otrhostatic hypotension | SYSTEMATIC_ASSESSMENT | Vascular disorders | MedDRA/JV.12.0 | View |
| Dislocation of joint prosthesis | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA/JV.12.0 | View |
| lacunar infarction | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA/JV.12.0 | View |
| intestinal obstruction | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA/JV.12.0 | View |
| postoperative wound infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA/JV.12.0 | View |
| hip fracture | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA/JV.12.0 | View |
| abcess jaw | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA/JV.12.0 | View |
| Transient ischaemic attack | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA/JV.12.0 | View |
| Subarachnoid haemorrhage | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA/JV.12.0 | View |
| gastroenteritis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA/JV.12.0 | View |
| deep vein thrombosis | SYSTEMATIC_ASSESSMENT | Vascular disorders | MedDRA/JV.12.0 | View |
| pelvic fracture | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA/JV.12.0 | View |
| herpes zoster | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA/JV.12.0 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Aspartate aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA/JV.12.0 | View |
| Gamma-glutamyltransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA/JV.12.0 | View |
| Blood urine present | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA/JV.12.0 | View |
| Blood alkaline phosphatase increased | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA/JV.12.0 | View |
| Haemorrhage subcutaneous | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA/JV.12.0 | View |
| Blood bilirubin increased | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA/JV.12.0 | View |
| headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA/JV.12.0 | View |
| Abdominal discomfort | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA/JV.12.0 | View |
| Haematuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | MedDRA/JV.12.0 | View |
| Alanine aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA/JV.12.0 | View |
| Diarrhoea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA/JV.12.0 | View |